SCHEMBL4564946

SCHEMBL4564946

COc1c(OC[C@@H](O)CN2C[C@@H](C)O[C@@H](C)C2)ccc2c1N=C(N)N1CCN=C21

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
PIK3CB P42338 5/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 2/20 0.41
KDM4E B2RXH2 2/20 0.39
POLB P06746 1/20 0.38
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PDE4D Q08499 2/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4565209 1.00 L3MBTL1 (0.47) L3MBTL1PIK3CBALDH1A1SMN1; SMN2GAA
SCHEMBL6730780 0.91 PIK3CB (0.45) L3MBTL1PIK3CBALDH1A1SMN1; SMN2GAA
SCHEMBL29824477 0.91 PIK3CB (0.45) L3MBTL1PIK3CBALDH1A1SMN1; SMN2GAA
SCHEMBL4565403 0.88 KDM4E (0.41) PIK3CBSMN1; SMN2TSHRKDM4EPOLB
SCHEMBL4565402 0.88 KDM4E (0.41) PIK3CBSMN1; SMN2TSHRKDM4EPOLB
SCHEMBL4565013 0.88 KDM4E (0.43) PIK3CBSMN1; SMN2TSHRKDM4EPOLB
SCHEMBL4565014 0.88 KDM4E (0.43) PIK3CBSMN1; SMN2TSHRKDM4EPOLB
SCHEMBL4543219 0.87 KDM4E (0.45) TSHRKDM4EPOLBMEN1KMT2A
SCHEMBL4543222 0.87 KDM4E (0.45) TSHRKDM4EPOLBMEN1KMT2A
SCHEMBL16798217 0.84 PIK3CB (0.50) L3MBTL1PIK3CBALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2638043-A1 ARYLAMINOALCOHOL-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINOLINES Bayer Intellectual Property GmbH (DE) 2013-09-18 EP disclosed
EP-2638045-A1 AMINOALCOHOL SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Intellectual Property GmbH (DE) 2013-09-18 EP disclosed
WO-2012062748-A1 AMINOALCOHOL SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-05-18 WO disclosed
WO-2012062743-A1 ARYLAMINOALCOHOL-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINOLINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-05-18 WO disclosed